000			01967 a2200541 4500
005			20250514193123.0
264		0	_c20040826
008			200408s 0 0 eng d
022			_a0027-8424
024	7		_a10.1073/pnas.0403390101 _2doi
040			_aNLM _beng _cNLM
100	1		_aMenendez, Javier A
245	0	0	_aInhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. _h[electronic resource]
260			_bProceedings of the National Academy of Sciences of the United States of America _cJul 2004
300			_a10715-20 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_a4-Butyrolactone _xanalogs & derivatives
650	0	4	_aAntibodies, Monoclonal _xmetabolism
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntifungal Agents _xmetabolism
650	0	4	_aAntineoplastic Agents _xmetabolism
650	0	4	_aApoptosis
650	0	4	_aBiomarkers, Tumor
650	0	4	_aBreast Neoplasms _xgenetics
650	0	4	_aCell Line
650	0	4	_aCell Size
650	0	4	_aCell Survival
650	0	4	_aCerulenin _xmetabolism
650	0	4	_aFatty Acid Synthases _xantagonists & inhibitors
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aGenes, erbB-2
650	0	4	_aHumans
650	0	4	_aOvarian Neoplasms _xgenetics
650	0	4	_aRNA, Small Interfering _xgenetics
650	0	4	_aReceptor, ErbB-2 _xgenetics
650	0	4	_aSignal Transduction
650	0	4	_aTranscription Factors _xgenetics
650	0	4	_aTrastuzumab
700	1		_aVellon, Luciano
700	1		_aMehmi, Inderjit
700	1		_aOza, Bharvi P
700	1		_aRopero, Santiago
700	1		_aColomer, Ramon
700	1		_aLupu, Ruth
773	0		_tProceedings of the National Academy of Sciences of the United States of America _gvol. 101 _gno. 29 _gp. 10715-20
856	4	0	_uhttps://doi.org/10.1073/pnas.0403390101 _zAvailable from publisher's website
999			_c14939190 _d14939190